Navigation Links
AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution
Date:8/19/2013

NEW YORK and NORCROSS, Ga., Aug. 19, 2013 /PRNewswire-iReach/ -- Identitas Corp., a leader in forensic phenotyping and AKESOgen, the genomics and biorepository services company today announced a global commercial partnership to offer the forensic industry an innovative turn-key phenotypic screening solution that allows investigators to generate more comprehensive leads from DNA samples than had previously been possible. Financial terms were not disclosed.

"Our unique technology creates highly specific phenotypic predictions from DNA, combining inferences on biogeographic ancestry, extended relatedness/kinship, gender, Y and mitochondrial haplotype, and physical appearance such as hair and eye color. ISAS™ is able to generate investigative leads rapidly using only a single aliquot of DNA. We evaluate genome-wide single nucleotide polymorphisms (SNPs), to extract greater insight from DNA samples than has previously been possible" said Dr. Aruna Bansal, CIO of Identitas.

"We are excited to be working with Identitas to provide a comprehensive solution which we believe is unique in the forensic market and will have tremendous utility for enhanced phenotyping of individuals for a variety of applications including missing person identification as well as investigative lead generation, to complement standard panels such as CODIS." commented Dr. Mark Bouzyk, CSO of AKESOgen.

The partnership will harness the combined strengths of both companies:  AKESOgen will provide an end-to-end genetic analysis package powered by Identitas's proprietary ISAS™ software analysis tool. ISAS™ employs a computationally powerful approach that interrogates single nucleotide polymorphisms (SNPs) to develop a profile that describes the physical appearance of an individual. AKESOgen has entered in to a license agreement with  Identitas for access to the ISAS™ software,  enabling customers a seamless delivery of an enhanced phenotypic profile from receipt of DNA. 

Media Contact: Aruna Bansal, Identitas, +44 1223 421 662, bansal@identitascorp.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Identitas Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
2. Newly discovered bacterial partnership changes ocean chemistry
3. Transatlantic partnership to tackle neurodegenerative disease
4. Advance Research Associates Partners With MedNet Solutions
5. NOAA, partners predict possible record-setting deadzone for Gulf of Mexico
6. Emotient and iMotions Partner to Offer Unique Integrated Facial Expression Recognition, Bio Sensor and Eye Tracking Solution for Usability, Gaming, Market and Academic/ Scientific Research
7. The DOE Joint Genome Institute expands capabilities via new partnerships
8. TGen and Riddell announce partnership for biomarker study of concussive injuries
9. Capco Partners with EyeLock to Bring Iris Biometric Security to Banks
10. BGI Health forms partnership with ACIBADEM hospital on genetic disease testing
11. Joint air toxics research project among tribes, agencies recognized for partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology: